Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

11 Oct 2012 07:00

RNS Number : 3629O
Polar Capital Holdings PLC
11 October 2012
Β 

ο»Ώ

11 October 2012

Β 

Polar Capital Holdings plc

AUM Update

Β 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

Β 

Group AUMΒ (unaudited)

Β 

As at 30 September 2012 the Group's AUM increased by 4.3% to $5.30bn from the $5.08bn reported at 31 March 2012. This also represents a 34.5% increase in AUM from the $3.94bn reported at 30 September 2011.

Β 

The table below sets out the movements in the Group's AUM over the six month period:

Β 

AUM movement

Six months to 30 September 2012

Long only funds

$m

Hedge funds

$m

Total

$m

As at 31 March 2012

$4,365m

$718m

$5,083m

Net subscriptions

$371m

$34m

$405m

Market movement and performance

$(193)m

$7m

$(186)m

Total AUM at 30 September 2012

$4,543m

$759m

$5,302m

Β 

Comment

Β 

Polar Capital has received $405m of net inflows in its first half year, $31m of which in the last quarter. It is encouraging that, although there were market driven outflows from some of the Group's larger long only strategies, these were more than covered by inflows into a number of the Group's nascent long only strategies. In addition, positive net inflows into the Group's hedge fund products, which started in the previous quarter, continued to gain momentum in this quarter. Importantly, these flow patterns further enhance the continued diversification of the Group's offerings as well as reducing the firm's legacy concentration risk.

Β 

We consider that as the performance of the Group's products remains good, the Group is well positioned to continue to grow its assets under management over the approaching quarters, assuming that market conditions do not deteriorate further.

Β 

Net performance fees (unaudited)

Β 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first six months of the Group's financial year. The majority of the Group's performance fees crystallise in the second half of the financial year.

Β 

Performance fees

net of staff allocations

Six months to

30 Sept 11

Β£m

Year to

31 Mar 12

(year-end)

Β£m

Six months to

30 Sept 12

Β£m

Received

Β£1.5m

Β£4.1m

Β£0.0m

Accrued but not yet earned in funds with year ends on or before the financial year end

Β£1.6m

n/a

Β£4.2m

Total net performance fees

Β£3.1m

Β£4.1m

Β£4.2m

Β 

Β 

For further information please contact:

Β 

Polar Capital

Tim Woolley (CEO)John Mansell (CFO)

Canaccord Genuity - Nomad and Broker

Simon Bridges

Cameron Duncan

F T I Consulting

Ed Gascoigne-Pees

Jack Hickey

Β 

Β 

+44 (0)20 7227 2700

Β 

Β 

+44 (0)20 7523 8000

Β 

Β 

+44 (0)20 7269 7132

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAPEEFESAFEF
Date   Source Headline
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20208:37 amRNSIssue of Equity
2nd Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
21st Feb 202011:51 amRNSForm 8.3 - Redde PLC
21st Feb 20209:59 amRNSIssue of Equity
20th Feb 20201:54 pmRNSForm 8.3 - Redde PLC
18th Feb 202011:14 amRNSForm 8.3 - Redde PLC
18th Feb 202010:28 amRNSChange of Auditor
17th Feb 20202:44 pmRNSForm 8.3 - Redde PLC
13th Feb 20202:37 pmRNSIssue of Equity
13th Feb 20207:00 amRNSTeam Acquisition
7th Feb 20201:09 pmRNSForm 8.3 - Redde PLC
6th Feb 20202:45 pmRNSForm 8.3 - Redde PLC
5th Feb 20202:33 pmRNSForm 8.3 - Redde PLC
3rd Feb 202011:14 amRNSBlock listing Interim Review
28th Jan 20201:06 pmRNSForm 8.3 - Redde PLC
22nd Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
21st Jan 20202:26 pmRNSForm 8.3 - Redde PLC
21st Jan 20202:12 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20202:01 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20201:37 pmRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
16th Jan 202012:28 pmRNSForm 8.3 - Redde PLC
16th Jan 202012:26 pmRNSForm 8.3 - Consort Medical PLC
15th Jan 202012:20 pmRNSForm 8.3 - Redde PLC
14th Jan 202012:00 pmRNSForm 8.3 - Redde PLC
13th Jan 20201:49 pmRNSForm 8.3 - Redde Plc
10th Jan 20201:09 pmRNSForm 8.3 - Redde Plc
9th Jan 20207:00 amRNSAuM Update
30th Dec 201912:35 pmRNSForm 8.3 - Redde PLC
24th Dec 201911:35 amRNSForm 8.3 - Redde PLC
23rd Dec 20193:24 pmRNSForm 8.3 - Redde PLC
20th Dec 201911:18 amRNSForm 8.3 - Redde PLC
19th Dec 20192:17 pmRNSForm 8.3 - Redde PLC
18th Dec 20191:42 pmRNSForm 8.3 - Consort Medical PLC
17th Dec 201910:58 amRNSForm 8.3 - Consort Medical Plc
17th Dec 20199:37 amRNSHolding(s) in Company
6th Dec 20191:09 pmRNSForm 8.3 - Consort Medical Plc
5th Dec 20192:24 pmRNSForm 8.3 - Consort Medical Plc
4th Dec 20191:22 pmRNSForm 8.3 - Consort Medical Plc
2nd Dec 20191:59 pmRNSForm 8.3 - Redde PLC
2nd Dec 20197:00 amRNSTotal Voting Rights
25th Nov 20197:00 amRNSUnaudited interim results
20th Nov 20194:40 pmRNSSecond Price Monitoring Extn
20th Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20191:52 pmRNSBlock Listing Application
20th Nov 20191:30 pmRNSCrystallisation of Business Unit & Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.